- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 55.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 55.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 55.39M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $16.8M |
| Capex | Q1 2026 · Mar 31, 2025 | $13.14M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $325.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$68.73M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.35B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.32B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.28B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $720.26M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.59B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.42B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.82B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.28B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.14B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.87B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.56B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.44 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.96 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.44 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.96 |
| Net Income | Q1 2026 · Mar 31, 2026 | $190.42M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$108.33M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.54B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.39B |